AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster autoimmune drug Rinvoq for the treatment of adults ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AbbVie's upadacitinib (Rinvoq) to treat adults with giant cell arteritis (GCA).

Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the ...

AbbVie’s scientists discovered and developed Rinvoq. Credit: © AbbVie Inc. All rights reserved. The European Medicines Agency’s Committee for Medicinal Products ...

The EU regulator has cleared Rinvoq (upadacitinib) as an oral treatment for moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older, either with or without topical ...

Use cases for AI in extended reality (XR) applications are truly limitless. AI can support visualisations of natural phenomena by pre-processing data. For example, a research team from the ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ahead of AbbVie’s Rinvoq and Skyrizi three months into its ...

People with inflammatory bowel disease (IBD) may be at an increased risk for complications from the flu (influenza). That's because IBD affects the immune system, and medications used to treat ...

The Honda XR125L is not a 'true' XR (just check out the electric start and the large tank range) maybe, but this is a great little commuter and green-laner. It lacks power up top but there’s ...